We report a 46-year-old woman presenting with leprosy, HIV and active pulmonary tuberculosis (TB). It is advisable to screen for each one of TB, HIV and leprosy patients, especially when an extra feature emerges. Particularly in a leprosy case, if TB remains undiagnosed, the development of rifampicin resistance secondary to monotherapy in leprosy is a major concern.
RawsonTMAnjumVHodgsonJet al.Leprosy and tuberculosis concomitant infection: a poorly understood, age-old relationship. Lepr Rev2014; 85: 288–295.
2.
CorbettELWattCJWalkerNet al.The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med2003; 163: 1009–1021.
3.
ManosuthiWChottanapandSThongyenSet al.Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr2006; 43: 42–46.
4.
LockwoodDNLambertSM. Human immunodeficiency virus and leprosy: an update. Dermatol Clin2011; 29: 125–128.
5.
SreeramareddyCTMenezesRGKishoreP. Concomitant age old infections of mankind - tuberculosis and leprosy: a case report. J Med Case Rep2007; 1: 43–43.
6.
KumarBKaurSKatariaSet al.Concomitant occurrence of leprosy and tuberculosis–a clinical, bacteriological and radiological evaluation. Lepr India1982; 54(4): 671–676.
7.
FinchCKChrismanCRBaciewiczAMet al.Rifampin and rifabutin drug interactions: an update. Arch Intern Med2002; 162: 985–992.
8.
KwobahCMWools-KaloustianKKGitauJNet al.Human immunodeficiency virus and leprosy coinfection: challenges in resource-limited setups. Case Rep Med2012; 2012: 698513–698513.
